MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Bio-Rad Laboratories General and Administrative Expenses 2011-2026 | BIO
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Bio-Rad Laboratories
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 814 M | 842 M | 828 M | 877 M | 799 M | 825 M | 835 M | 809 M | 817 M | 762 M | 808 M | 798 M | 683 M | 696 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 877 M | 683 M | 799 M |
Quarterly General and Administrative Expenses Bio-Rad Laboratories
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 208 M | 209 M | 200 M | 195 M | 215 M | 201 M | 208 M | 226 M | - | 211 M | 208 M | 197 M | - | 216 M | 213 M | 226 M | - | 198 M | 189 M | 194 M | - | 202 M | 201 M | 208 M | - | 201 M | 210 M | 209 M | 202 M | 198 M | 212 M | 194 M | 220 M | 202 M | 206 M | 190 M | - | 187 M | 193 M | 189 M | - | 203 M | 196 M | 202 M | - | 202 M | 195 M | 186 M | - | 160 M | 162 M | 171 M | - | 177 M | 177 M | 168 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 226 M | 160 M | 199 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 12.03 | -0.33 % | $ 1.63 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
16.5 M | $ 9.06 | -3.41 % | $ 257 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
894 M | $ 36.22 | -1.42 % | $ 5.4 K | USA |
 |
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
120 M | $ 15.68 | -1.63 % | $ 368 M | USA |
 |
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
1.76 B | $ 166.59 | -3.07 % | $ 12.5 B | USA |
 |
AxoGen
AXGN
|
44.6 M | $ 30.87 | -5.44 % | $ 1.42 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | USA |
 |
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.44 | -2.0 % | $ 129 M |  France |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
39.8 M | $ 4.01 | -3.14 % | $ 849 M | USA |
 |
Smith & Nephew plc
SNN
|
2.72 B | $ 31.7 | -2.85 % | $ 23.8 B |  Britain |
 |
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
35.6 M | $ 0.58 | -1.69 % | $ 36.1 M | USA |
 |
TELA Bio
TELA
|
15.7 M | $ 0.67 | 5.89 % | $ 31.5 M | USA |
 |
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 9.63 | -0.72 % | $ 345 M | USA |
 |
BioSig Technologies
BSGM
|
67.5 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
6.89 B | $ 61.38 | -1.92 % | $ 90.9 B | USA |
 |
Alphatec Holdings
ATEC
|
499 M | $ 11.14 | 1.55 % | $ 1.67 B | USA |
 |
CONMED Corporation
CNMD
|
132 M | $ 34.09 | 0.07 % | $ 1.06 B | USA |
 |
FONAR Corporation
FONR
|
23.5 M | $ 18.6 | - | $ 122 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
2.09 B | $ 80.75 | -0.49 % | $ 47.2 B | USA |
 |
Globus Medical
GMED
|
1.18 B | $ 90.0 | 1.55 % | $ 12.2 B | USA |
 |
Helius Medical Technologies
HSDT
|
9.27 M | $ 1.74 | -8.38 % | $ 1.06 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
717 M | $ 9.32 | 0.11 % | $ 718 M | USA |
 |
Inspire Medical Systems
INSP
|
625 M | $ 54.12 | -0.01 % | $ 1.59 B | USA |
 |
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | USA |
 |
IRIDEX Corporation
IRIX
|
7.73 M | $ 1.0 | 0.34 % | $ 16.9 M | USA |
 |
Integer Holdings Corporation
ITGR
|
212 M | $ 85.59 | -0.04 % | $ 2.97 B | USA |
 |
LENSAR
LNSR
|
45.2 M | $ 5.85 | -0.68 % | $ 70 M | USA |
 |
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
63.3 M | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
10.8 B | $ 86.29 | - | $ 111 B | USA |
 |
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
54.3 M | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
14 M | $ 0.66 | -5.67 % | $ 27.6 M | USA |